PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Income
-$16.55M
Quarterly · Period ending: · USD
PHAS Operating Income
Latest reported-$16.55Mperiod ending
Latest reported-$16.55Mperiod ending
PHAS Quarterly Operating Income (-$1.90M → -$16.55M)
Quarterly operating income
High-resolution chart · PNG
PHAS operating income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income (USD) |
|---|---|
| -16,549,000 | |
| -10,993,000 | |
| 85,469,582 | |
| -28,576,000 | |
| -21,053,000 | |
| -25,647,000 | |
| -25,978,000 | |
| -20,492,000 | |
| -24,098,000 | |
| -14,288,000 | |
| -11,280,000 | |
| -11,590,000 | |
| -9,482,000 | |
| -7,384,000 | |
| -7,660,000 | |
| -4,999,000 | |
| -4,107,000 | |
| -2,878,000 | |
| -2,451,000 | |
| -1,895,000 |